Home › Compare › EVRN vs ABBV

EVRN vs ABBV: Dividend Comparison 2026

EVRN yields 2000000.00% · ABBV yields 3.67%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EVRN wins by $4.879226400974806e+39M in total portfolio value
10 years
EVRN
EVRN
● Live price
2000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.879226400974806e+39M
Annual income
$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00
Full EVRN calculator →
ABBV
AbbVie Inc.
● Live price
3.67%
Share price
$168.90
Annual div
$6.20
5Y div CAGR
8.9%
Payout ratio
58%
After 10 yrs · $10,000 · DRIP
Portfolio value
$39.9K
Annual income
$1,154.43
Full ABBV calculator →

Portfolio growth — EVRN vs ABBV

📍 EVRN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEVRNABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EVRN + ABBV cover 4 of 12 months — good coverage

Jan
ABBV
Feb
—
Mar
—
Apr
ABBV
May
—
Jun
—
Jul
ABBV
Aug
—
Sep
—
Oct
ABBV
Nov
—
Dec
—
EVRN pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EVRN
Annual income on $10K today (after 15% tax)
$170,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/yr
ABBV
Annual income on $10K today (after 15% tax)
$312.02/yr
After 10yr DRIP, annual income (after tax)
$981.27/yr
At 15% tax rate, EVRN beats the other by $4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EVRN + ABBV for your $10,000?

EVRN: 50%ABBV: 50%
100% ABBV50/50100% EVRN
Portfolio after 10yr
$2.439613200487403e+39M
Annual income
$2,439,373,269,665,485,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

EVRN
No analyst data
ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+51.7% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EVRN buys
0
ABBV buys
0
No recent congressional trades found for EVRN or ABBV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEVRNABBV
Forward yield2000000.00% ✓3.67%
Annual dividend / share$2.00$6.20 ✓
Payout ratio50% ✓58%
1-year div growth0%4.7% ✓
5-year div CAGR0%8.9% ✓
Portfolio after 10y$4.879226400974806e+39M$39.9K ✓
Annual income after 10y$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00 ✓$1,154.43
Total dividends collected$4.879195005460081e+39M$7.2K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: EVRN vs ABBV ($10,000, DRIP)

YearEVRN PortfolioEVRN Income/yrABBV PortfolioABBV Income/yrGap
1← crossover$200,010,700$200,000,000.00$11,520$399.75+$200.00M → EVRN
2$3,738,731,768,458$3,738,517,757,009.35$13,261$450.98+$3738731.76M → EVRN
3$65,315,062,866,930,490$65,311,062,423,938,240.00$15,255$508.41+$65315062866.92M → EVRN
4$1,066,400,830,062,625,000,000$1,066,330,942,945,357,500,000.00$17,536$572.74+$1066400830062625.00M → EVRN
5$16,272,182,796,453,826,000,000,000$16,271,041,747,565,660,000,000,000.00$20,145$644.78+$16272182796453826560.00M → EVRN
6$232,054,240,113,661,900,000,000,000,000$232,036,828,878,069,680,000,000,000,000.00$23,126$725.38+$2.3205424011366188e+23M → EVRN
7$3,092,799,066,104,688,500,000,000,000,000,000$3,092,550,768,067,767,400,000,000,000,000,000.00$26,532$815.52+$3.0927990661046884e+27M → EVRN
8$38,524,105,697,352,694,000,000,000,000,000,000,000$38,520,796,402,351,967,000,000,000,000,000,000,000.00$30,420$916.26+$3.8524105697352695e+31M → EVRN
9$448,468,826,014,798,700,000,000,000,000,000,000,000,000$448,427,605,221,702,600,000,000,000,000,000,000,000,000.00$34,855$1,028.80+$4.484688260147987e+35M → EVRN
10$4,879,226,400,974,806,000,000,000,000,000,000,000,000,000,000$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00$39,914$1,154.43+$4.879226400974806e+39M → EVRN

EVRN vs ABBV: Complete Analysis 2026

EVRN — Stock

Everock, Inc. produces and sells sandwich spreads and dips for delis, restaurants, cafeterias, and club stores. It offers vegetable dishes and gourmet sandwich spreads. The company sells its products online for customers in the United States and internationally. Everock, Inc. was formerly known as Nature's Peak, Inc. and changed its name to Everock, Inc. in July 2009. The company is based in Santa Cruz, California.

Full EVRN Calculator →

ABBV — Healthcare

AbbVie is a pharmaceutical giant best known for Humira and newer blockbusters Skyrizi and Rinvoq. A Dividend Aristocrat with 52+ years of consecutive dividend increases. Strong free cash flow generation supports its above-average yield. The company's diversified pipeline reduces dependence on any single drug.

Full ABBV Calculator →
📬

Get this EVRN vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EVRN vs SCHDEVRN vs JEPIEVRN vs OEVRN vs KOEVRN vs MAINEVRN vs JNJEVRN vs MRKEVRN vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.